How does Atorvastatin influence inflammatory markers in cardiovascular diseases, and does it provide added benefits for patients with chronic inflammation?
Sahil KapoorExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Atorvastatin reduces inflammatory markers like CRP in cardiovascular diseases, potentially lessening chronic inflammation and thereby reducing future cardiac risks.
Atorvastatin has been shown to lower levels of C-reactive protein and other inflammatory markers, which may decrease the risk of cardiovascular events in patients with chronic inflammation.